Liver Transplantation for Patients with Alcoholic Hepatitis
With advances in the prevention and therapy of viral hepatitis, the percentage of patients with alcohol-associated liver disease requiring liver transplantation is increasing with a growing recognition of liver transplantation as a rescue therapy for individuals with severe alcoholic hepatitis (AH) not responding to medical therapy. Treatment guidelines adopted by most liver transplantation centers require a six-month period of alcohol abstinence and counseling prior to candidacy for liver replacement. In many cases individuals with severe AH do not have the luxury of waiting and are unlikely to survive six months. This session will review liver transplantation for alcoholic liver disease, discuss the selection process to evaluate eligibility on a case-by-case basis, address specific factors that should be considered during evaluation, and explore whether a mandatory period of abstinence is a predictor of relapse and the ethical considerations surrounding such a requirement for patients’ transplant eligibility.
This activity is provided by OptumHealth Education.
No commercial support was received for this activity.
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software prior to the beginning of this activity.
This activity is designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians and other health care professionals (HCPs) who are interested in the care of patients with alcoholic liver disease.
At the end of this educational activity, participants should be able to:
- Review liver transplantation for alcoholic liver disease, including the selection process for transplant eligibility.
- Identify specific factors that should be addressed when evaluating individuals for liver transplant.
- Discuss whether a mandatory period of alcohol abstinence is a predictor of relapse.
- Explore ethical considerations on the eligibility of liver transplant candidates.
Sarah Chart, RN
Eden Prairie, MN
Rebecca Gleason, RN, CCM
Eden Prairie, MN
C. Fred LeMaistre, MD
Senior Vice President
Sarah Cannon Market Operations
Physician in Chief of Blood Cancers
Tina Rydland, PharmD
Crystal Clear Rx
Disclosures of relevant financial relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education requires all those in the control of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or his/her spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services relate to the activity content.
OptumHealth Education ensures that the content is independent of commercial bias.
Ms. Chart and Ms. Gleason have indicated that they are employees of and own stock in UnitedHealth Group.
The remaining activity faculty or planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
In support of improving patient care, OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit designation statements
This activity was planned by and for the health care team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
The participant will be awarded up to 1.00 contact hour(s) of credit for attendance and completion of supplemental materials.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
This activity is approved for 1.00 contact hour ([0.10] CEU) in states that recognize ACPE.
Attending the full program will earn 1.00 contact hour.
Unique Activity Number(s): JA0007123-0000-19-192-H01-P/T
OptumHealth Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
This activity has been pre-approved by the Commission for Case Manager Certification to provide Ethics continuing education credit to Certified Case Managers (CCMs). The course is approved for 1.0 CE contact hours. Activity code: I00038290; Approval Number: 190002811
CCMC Ethics credit is approved for this course. The CCMC Code of Professional Conduct will be referenced in these presentations. View the CCMC Code of Professional Conduct here.
To claim these CEs, log into your CE Center account at www.ccmcertification.org.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization from which they wish to obtain credit.
- 1.00 ACPE - Pharmacist
- 1.00 ACPE - Pharmacy Technician
- 1.00 AMA
- 1.00 ANCC
- 1.00 Attendance
- 1.00 CCMC - Ethics
You must be logged into your account to participate in this activity. Get started by clicking “Continue”. Then follow the Activity Instructions. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”